Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 7 of 38
Retrospective Review of Esophageal Cancer at MSKCC
NCT05706558
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
NCT02974647
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
NCT02772367
Lymphedema Surveillance Study
NCT02743858
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
NCT02677064
Pilot Trial of Homebound Stem Cell Transplantation
NCT02671448
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
NCT02706561
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
NCT02507141
Psychotherapy Intervention for Latinos With Advanced Cancer
NCT04015609
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
NCT02422550
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
NCT02421380
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
NCT02393703
Genomic Predictors of Papillary Microcarcinoma Disease Progression
NCT02363595
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
NCT02296450
Kidney Cancer DNA Registry
NCT02087852
Germ Cell Tumor and Testicular Tumor DNA Registry
NCT02099734
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
NCT01788839
Genomic Profiling in Cancer Patients
NCT01775072
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
NCT01742143
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
NCT01639508
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
NCT00870129
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT00823654
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
NCT00107289
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
NCT00588185
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
NCT00579566
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
NCT00588068
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
NCT00582621
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy
NCT06671782
A Study of the BREAST-Q REACT Tool for People Having Breast Surgery
NCT06550401
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
NCT06448208
A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
NCT06373380
Study of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer
NCT06293456
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
NCT06240598
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
NCT06243757
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
NCT06168812
A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer
NCT06145412
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
NCT06132945
Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer
NCT06127836
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
NCT06126341
A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung Cancer
NCT06008574
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
NCT05806138
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
NCT05912244
A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
NCT05886634
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
NCT05678010
Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief
NCT05877521
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
NCT05892068
A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)
NCT05814549
A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer
NCT05793593
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
NCT05778825
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.